Is Doctor Strange in the Multiverse of Madness a Hit or Flop? Official Box Office Record & Profit Analysis

Detailed Financial Report

Doctor Strange in the Multiverse of Madness, released in 2022, entered the cinematic marketplace as a Fantasy / Action / Adventure film. The production path for this project involved significant capital, with a reported budget of approximately $290.0M. In the modern film economy, recovering such an investment requires a multifaceted theatrical strategy spanning domestic and international territories.

Collection Trajectory

The box office journey for Doctor Strange in the Multiverse of Madness has culminated in a worldwide gross of approximately $955.8M. This figure represents the total theatrical footprint, reflecting a Return on Investment (ROI) of 230%. This performance indicates a strong grasp of the target demographic and sustained momentum beyond the opening weekend, a hallmark of major commercial success.

Profitability & Verdict

Analyzing the multiplier effect and market sentiment, Doctor Strange in the Multiverse of Madness navigated the competitive landscape with an audience reception score of 7.2/10. When weighing the production costs against the global returns, Doctor Strange in the Multiverse of Madness is effectively categorized as a Super Hit. It stands as a testament to the power of high-concept storytelling and broad audience appeal.

Comparables

In the context of other Fantasy releases, the performance of Doctor Strange in the Multiverse of Madness will likely influence how studios approach similar projects in the future. Whether through its innovative visual style or its narrative choices, the film's financial footprint remains a key piece of the 2022 box office narrative.